Global Payments To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Thursday

• Keybanc cut the price target for i3 Verticals, Inc. IIIV from $28 to $26. Keybanc analyst Josh Beck maintained an Overweight rating. i3 Verticals shares fell 2.9% to close at $22.76 on Wednesday.
• Telsey Advisory Group increased Arhaus, Inc. ARHS price target from $13 to $15. Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating. Arhaus shares gained 8.7% to close at $12.61 on Wednesday.
• Piper Sandler boosted the price target for Wix.com Ltd. WIX from $120 to $130. Piper Sandler analyst Clarke Jeffries maintained an Overweight rating. Wix.com shares fell 0.7% to close at $90.41 on Wednesday.
• Raymond James increased the price target for FLEETCOR Technologies, Inc. FLT from $246 to $283. Raymond James analyst John Davis maintained an Outperform rating. FLEETCOR Technologies shares gained 6.3% to close at $260.04 on Wednesday.
• Needham cut Viridian Therapeutics, Inc. VRDN price target from $47 to $40. Needham analyst Serge Belanger maintained a Buy rating. Viridian Therapeutics shares rose 2.7% to close at $19.26 on Wednesday.
• HC Wainwright & Co. slashed Terns Pharmaceuticals, Inc. TERN price target from $11 to $8. HC Wainwright & Co. analyst Ed Arce maintained a Neutral rating. Terns Pharmaceuticals shares fell 13.7% to close at $6.03 on Wednesday.
• Stifel increased Deciphera Pharmaceuticals, Inc. DCPH price target from $14 to $20. Stifel analyst Bradley Canino upgraded the stock from Hold to Buy. Deciphera Pharmaceuticals shares gained 6.2% to close at $13.74 on Wednesday.
• Jefferies boosted Global Payments Inc. GPN price target from $125 to $145. Jefferies analyst Trevor Williams upgraded the stock from Hold to Buy. Global Payments shares fell 0.3% to close at $124.04 on Wednesday.
• DA Davidson slashed the price target for OneSpan Inc. OSPN from $19 to $12. DA Davidson analyst Andrew Nowinski downgraded the stock from Buy to Neutral. OneSpan shares fell 4.1% to $12.79 in pre-market trading.
• Goldman Sachs lowered Nuvei Corporation NVEI price target from $41 to $22. Goldman Sachs analyst Will Nance downgraded the stock from Buy to Neutral. Nuvei shares fell 0.6% to $18.02 in pre-market trading.
• Baird cut Decibel Therapeutics, Inc. DBTX price target from $21 to $5.25. Baird analyst Jack Allen downgraded the stock from Outperform to Neutral. Decibel Therapeutics shares fell 1.6% to $4.95 in pre-market trading.

Check This Out: Disney, Alibaba And 3 Stocks To Watch Heading Into Thursday